全文获取类型
收费全文 | 643篇 |
免费 | 62篇 |
专业分类
705篇 |
出版年
2023年 | 4篇 |
2022年 | 4篇 |
2021年 | 13篇 |
2020年 | 6篇 |
2019年 | 3篇 |
2018年 | 9篇 |
2017年 | 4篇 |
2016年 | 17篇 |
2015年 | 23篇 |
2014年 | 29篇 |
2013年 | 31篇 |
2012年 | 44篇 |
2011年 | 35篇 |
2010年 | 34篇 |
2009年 | 22篇 |
2008年 | 43篇 |
2007年 | 26篇 |
2006年 | 37篇 |
2005年 | 28篇 |
2004年 | 25篇 |
2003年 | 27篇 |
2002年 | 23篇 |
2001年 | 20篇 |
2000年 | 16篇 |
1999年 | 15篇 |
1998年 | 7篇 |
1997年 | 9篇 |
1996年 | 4篇 |
1995年 | 9篇 |
1994年 | 4篇 |
1993年 | 5篇 |
1992年 | 13篇 |
1991年 | 12篇 |
1990年 | 7篇 |
1989年 | 4篇 |
1987年 | 3篇 |
1986年 | 12篇 |
1984年 | 7篇 |
1983年 | 4篇 |
1981年 | 4篇 |
1979年 | 4篇 |
1978年 | 4篇 |
1976年 | 4篇 |
1973年 | 6篇 |
1970年 | 5篇 |
1969年 | 3篇 |
1962年 | 2篇 |
1959年 | 4篇 |
1954年 | 2篇 |
1953年 | 2篇 |
排序方式: 共有705条查询结果,搜索用时 23 毫秒
91.
Analysis of Loss of heterozygosity and immunohistochemistry in BRCA1 gene in sporadic breast cancers
Dinesh KP Devaraj H Murugan V Rajaraman R Niranjali S 《Molecular and cellular biochemistry》2006,287(1-2):177-183
BRCA1 is a tumour suppressor gene (TSG), which predisposes cancer to both breast and ovary. The primary objective of the present study is to ascertain the involvement of BRCA1 gene in the pathogenesis of sporadic breast cancer women in Chennai (South India) by analysing its protein expression by immunohistochemistry (IHC) and loss of heterozygosity (LOH) for confirmation of the involvement of TSG in the study population. We found down regulation of BRCA1 protein (54%) in IHC and it was correlated with the clinicopathological parameters of the patients. We found near significant correlation (P < 0.063) between BRCA1 protein expression and clinicopathological parameters. We found 30% LOH in our study and it was also correlated with the clinicopathological parameters. No correlation was found between LOH and clinicopathological parameters. Though we found no correlation, the results revealed in this study support the involvement of BRCA1 TSG in the pathogenesis of sporadic breast cancer women in Chennai (South India). 相似文献
92.
93.
Subramanian Swaminathan Vanamail Perumal Srividya Adinarayanan Krishnamoorthy Kaliannagounder Ravi Rengachari Jambulingam Purushothaman 《PLoS neglected tropical diseases》2012,6(11)
Background
Monitoring and evaluation guidelines of the programme to eliminate lymphatic filariasis require impact assessments in at least one sentinel and one spot-check site in each implementation unit (IU). Transmission assessment surveys (TAS) that assess antigenaemia (Ag) in children in IUs that have completed at least five rounds of mass drug administration (MDA) each with >65% coverage and with microfilaria (Mf) levels <1% in the monitored sites form the basis for stopping the MDA. Despite its rigour, this multi-step process is likely to miss sites with transmission potential (‘hotspots’) and its statistical assumptions for sampling and threshold levels for decision-making have not been validated. We addressed these issues in a large-scale epidemiological study in two primary health centres in Thanjavur district, India, endemic for bancroftian filariasis that had undergone eight rounds of MDA.Methodology/Principal Findings
The prevalence and intensity of Mf (per 60 µl blood) were 0.2% and 0.004 respectively in the survey that covered >70% of 50,363 population. The corresponding values for Ag were 2.3% and 17.3 Ag-units respectively. Ag-prevalence ranged from 0.7 to 0.9%, in children (2–10 years) and 2.7 to 3.0% in adults. Although the Mf-levels in the survey and the sentinel/spot check sites were <1% and Ag-level was <2% in children, we identified 7 “residual” (Mf-prevalence ≥1%, irrespective of Ag-status in children) and 17 “transmission” (at least one Ag-positive child born during the MDA period) hotspots. Antigenaemic persons were clustered both at household and site levels. We identified an Ag-prevalence of ∼1% in children (equivalent to 0.4% community Mf-prevalence) as a possible threshold value for stopping MDA.Conclusions/Significance
Existence of ‘hotspots’ and spatial clustering of infections in the study area indicate the need for developing good surveillance strategies for detecting ‘hotspots’, adopting evidence-based sampling strategies and evaluation unit size for TAS. 相似文献94.
Phospholipase D1 plays a key role in TNF-alpha signaling 总被引:1,自引:0,他引:1
Sethu S Mendez-Corao G Melendez AJ 《Journal of immunology (Baltimore, Md. : 1950)》2008,180(9):6027-6034
The primary characteristic features of any inflammatory or infectious lesions are immune cell infiltration, cellular proliferation, and the generation of proinflammatory mediators. TNF-alpha is a potent proinflammatory and immuno-regulatory cytokine. Decades of research have been focused on the physiological/pathophysiological events triggered by TNF-alpha. However, the signaling network initiated by TNF-alpha in human leukocytes is still poorly understood. In this study, we report that TNF-alpha activates phospholipase D1 (PLD1), in a dose-dependent manner, and PLD1 is required for the activation of sphingosine kinase and cytosolic calcium signals. PLD1 is also required for NFkappaB and ERK1/2 activation in human monocytic cells. Using antisense oligonucleotides to reduce specifically the expression of PLD isozymes showed PLD1, but not PLD2, to be coupled to TNF-alpha signaling and that PLD1 is required to mediate receptor activation of sphingosine kinase and calcium transients. In addition, the coupling of TNF-alpha to activation of the phosphorylation of ERK1/2 and the activation of NFkappaB were inhibited by pretreating cells with antisense to PLD1, but not to PLD2; thus, demonstrating a specific requirement for PLD1. Furthermore, use of antisense oligonucleotides to reduce expression of PLD1 or PLD2 demonstrated that PLD1 is required for TNF-alpha-induced production of several important cytokines, such as IL-1beta, IL-5, IL-6, and IL-13, in human monocytes. These studies demonstrate the critical role of PLD1 in the intracellular signaling cascades initiated by TNF-alpha and its functional role for coordinating the signals to inflammatory responses. 相似文献
95.
Srinivasan Rajaraman Andrei V Gribok Nancy J Wesensten Thomas J Balkin Jaques Reifman 《Journal of applied physiology》2008,104(2):459-468
We present a new method for developing individualized biomathematical models that predict performance impairment for individuals restricted to total sleep loss. The underlying formulation is based on the two-process model of sleep regulation, which has been extensively used to develop group-average models. However, in the proposed method, the parameters of the two-process model are systematically adjusted to account for an individual's uncertain initial state and unknown trait characteristics, resulting in individual-specific performance prediction models. The method establishes the initial estimates of the model parameters using a set of past performance observations, after which the parameters are adjusted as each new observation becomes available. Moreover, by transforming the nonlinear optimization problem of finding the best estimates of the two-process model parameters into a set of linear optimization problems, the proposed method yields unique parameter estimates. Two distinct data sets are used to evaluate the proposed method. Results of simulated data (with superimposed noise) show that the model parameters asymptotically converge to their true values and the model prediction accuracy improves as the number of performance observations increases and the amount of noise in the data decreases. Results of a laboratory study (82 h of total sleep loss), for three sleep-loss phenotypes, suggest that individualized models are consistently more accurate than group-average models, yielding as much as a threefold reduction in prediction errors. In addition, we show that the two-process model of sleep regulation is capable of representing performance data only when the proposed individualized model is used. 相似文献
96.
The global impact of the converging dual epidemics of tuberculosis (TB) and human immunodeficiency virus (HIV) is one of the
major public health challenges of our time. The World Health Organization (WHO) reports 9.2 million new cases of TB in 2006
of whom 7.7% were HIV-infected. Tuberculosis is the most common opportunistic infection in HIV-infected patients as well as
the leading cause of death. Further, there has been an increase in rates of drug resistant tuberculosis, including multi-drug
(MDRTB) and extensively drug resistant TB (XDRTB), which are difficult to treat and contribute to increased mortality. The
diagnosis of TB is based on sputum smear microscopy, a 100-year old technique and chest radiography, which has problems of
specificity. Extra-pulmonary, disseminated and sputum smear negative manifestations are more common in patients with advanced
immunosuppression. Newer diagnostic tests are urgently required that are not only sensitive and specific but easy to use in
remote and resource-poor settings. Treatment of HIV-TB co-infection is complex and associated with high pill burden, overlapping
drug toxicities, risk of immune reconstitution inflammatory syndrome (IRIS) and challenges related to adherence. From a programmatic
point of view, screening of all HIV-infected persons for tuberculosis and vice-versa will help identify co-infected patients
who require treatment for both infections. This requires good coordination and communication between the TB and AIDS control
programs, in India. 相似文献
97.
98.
99.
Imidazolonepropionase (HutI) (imidazolone-5-propanote hydrolase, EC 3.5.2.7) is a member of the amidohydrolase superfamily and catalyzes the conversion of imidazolone-5-propanoate to N-formimino-L-glutamate in the histidine degradation pathway. We have determined the three-dimensional crystal structures of HutI from Agrobacterium tumefaciens (At-HutI) and an environmental sample from the Sargasso Sea Ocean Going Survey (Es-HutI) bound to the product [ N-formimino-L-glutamate (NIG)] and an inhibitor [3-(2,5-dioxoimidazolidin-4-yl)propionic acid (DIP)], respectively. In both structures, the active site is contained within each monomer, and its organization displays the landmark feature of the amidohydrolase superfamily, showing a metal ligand (iron), four histidines, and one aspartic acid. A catalytic mechanism involving His265 is proposed on the basis of the inhibitor-bound structure. This mechanism is applicable to all HutI forms. 相似文献
100.
Brca2 (XRCC11) Deficiency Results in Radioresistant DNA Synthesis and a Higher Frequency of Spontaneous Deletions 总被引:1,自引:0,他引:1 下载免费PDF全文
Maria Kraakman-van der Zwet Wilhelmina J. I. Overkamp Rebecca E. E. van Lange Jeroen Essers Annemarie van Duijn-Goedhart Ingrid Wiggers Srividya Swaminathan Paul P. W. van Buul Abdellatif Errami Raoul T. L. Tan Nicolaas G. J. Jaspers Shyam K. Sharan Roland Kanaar Magorzata Z. Zdzienicka 《Molecular and cellular biology》2002,22(2):669-679
We show here that the radiosensitive Chinese hamster cell mutant (V-C8) of group XRCC11 is defective in the breast cancer susceptibility gene Brca2. The very complex phenotype of V-C8 cells is complemented by a single human chromosome 13 providing the BRCA2 gene, as well as by the murine Brca2 gene. The Brca2 deficiency in V-C8 cells causes hypersensitivity to various DNA-damaging agents with an extreme sensitivity toward interstrand DNA cross-linking agents. Furthermore, V-C8 cells show radioresistant DNA synthesis after ionizing radiation, suggesting that Brca2 deficiency affects cell cycle checkpoint regulation. In addition, V-C8 cells display tremendous chromosomal instability and a high frequency of abnormal centrosomes. The mutation spectrum at the hprt locus showed that the majority of spontaneous mutations in V-C8 cells are deletions, in contrast to wild-type V79 cells. A mechanistic explanation for the genome instability phenotype of Brca2-deficient cells is provided by the observation that the nuclear localization of the central DNA repair protein in homologous recombination, Rad51, is reduced in V-C8 cells. 相似文献